Ticker
GERNCompany Name
GERON CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Debt | Shareholders Equity | Invested Capital |
---|---|---|---|
6/30/2025 | $ 249.81M | $ 259.53M | $ 509.34M |
3/31/2025 | $ 247.69M | $ 268.24M | $ 515.93M |
12/31/2024 | $ 246.51M | $ 280.32M | $ 526.83M |
9/30/2024 | $ 87.26M | $ 292.28M | $ 379.55M |
6/30/2024 | $ 87.04M | $ 306.69M | $ 393.74M |
3/31/2024 | $ 86.53M | $ 344.87M | $ 431.4M |
12/31/2023 | $ 85.9M | $ 247.95M | $ 333.85M |
9/30/2023 | $ 56.02M | $ 290.61M | $ 346.63M |
6/30/2023 | $ 55.93M | $ 298.43M | $ 354.36M |
3/31/2023 | $ 55.84M | $ 326.06M | $ 381.9M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt + Equity
(=) Inv. Capital
Inv. Capital for GERON CORP is calculated as follows: Debt [ $ 29.68M ] + Equity [ $ 232.83M ]
(=) Inv. Capital [ $ 262.51M ]
Minimum
Dec 31, 2022
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 3.44K |
---|---|
min | $ -1.51B |
max | $ 4.11B |
average | $ 760.31M |
median | $ 303.21M |
std | $ 1B |